Milestone Fundraising

How biotech creates billion dollar moats through regulatory hurdles

Celine Halioua explains how biotech companies build defensible moats through difficult regulatory and technical barriers, then structure fundraising around milestones that increase the probability of reaching approval and unlocking massive market value. She breaks down the strategic thinking behind milestone-based fundraising in regulated industries.